- Home
- CZWI vs NBP Comparison
CZWI vs NBP Comparison
Compare CZWI & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZWI | NBP |
|---|---|---|
| Founded | 1938 | 2014 |
| Country | United States | United States |
| Employees | N/A | 30 |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.1M | 225.5M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CZWI | NBP |
|---|---|---|
| Price | $23.36 | $1.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 115.8K | ★ 770.0K |
| Earning Date | 04-27-2026 | 04-07-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 8.96 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.02 | N/A |
| Revenue Next Year | $9.42 | N/A |
| P/E Ratio | $58.85 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.61 | $1.46 |
| 52 Week High | $24.43 | $5.19 |
Technical Indicators
Market Signals| Indicator | CZWI | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 59.95 | 51.45 |
| Support Level | $20.10 | $1.67 |
| Resistance Level | $24.43 | $1.95 |
| Average True Range (ATR) | 0.74 | 0.17 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 61.20 | 41.45 |
Price Performance
Historical ComparisonAbout CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.